In this podcast, Timothy Bhattacharyya, MD, discusses declining trends in hip fractures seen over the last 40 years, how osteoporosis treatment efforts relate to these trends, and what factors have had the...
Elizabeth Volkmann, MD, discusses her research into the association of the gut microbiome with systemic sclerosis, environmental influences on the microbiota, and advances in treating the disease.
In this podcast, Harrys A. Torres, MD, talks about his team's study that aimed to identify the optimal screening test for hepatitis C virus in patients with hematologic malignancies and/or prior...
In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also...
In this podcast, Ganesh Raghu, MD, speaks about idiopathic pulmonary fibrosis and the importance of eliminating all causes and conditions that can cause pulmonary fibrosis with features of usual...
In this podcast, Christian Sandrock, MD, MPH, talks about the burden of community-acquired bacterial pneumonia (CABP) in the United States, including the financial burden, the burden on hospitals, and...
In part 1 of this podcast series, Vincent Lo Re, MD, talks about the current knowledge gaps around hepatitis C virus screening, as well as how health care providers can implement better screening protocols...
Ricardo Cohen, MD, discusses his research on the safety and effectiveness of Roux-en-Y gastric bypass surgery for the early treatment of CKD among patients with obesity and type 2 diabetes, and why, despite...
Kristin Highland, MD, provides an overview of systemic sclerosis and associated interstitial lung disease, including symptoms and diagnosis, who's at risk, and new and upcoming treatments for this complex...
In this podcast, Meredith Sloan, MD, talks about the ways that statins have improved clinical outcomes for patients with community-acquired pneumonia (CAP), including what is next for research on statins...
